English 中文

About Decheng Capital

Decheng Capital is a leading healthcare investment firm that provides capital to early and growth stage life science companies in China and the U.S. We are a team of investment professionals has complementary expertise, a long history of working together and a shared dedication to building highly successful companies that span the full spectrum of the life sciences industry. Our domain knowledge, access to innovative technologies and ability to bring proven Western products to China makes them the preferred partner for entrepreneurs, domestic and multinational companies, government agencies and investors. Decheng Capital is poised to capitalize on a historic opportunity in China’s rapidly developing life sciences industry and to deliver superior returns for our investors.



June 1, 2016
AccuraGen Raises $40M in Series B Financing

March 29, 2016
Dennis Lo, Co-founder of Cirina, featured on CNN

August 25, 2015
Becton Dickinson Acquires Single-Cell Genomics Startup Cellular Research

August 13, 2015
Roche Acquires GeneWEAVE for up to $425 Million to Strengthen Offerings in Microbiology Diagnostics

May 26, 2015
3SBio Attracts $712 million Hong Kong IPO


Copyright © 2011 Decheng Capital LLC. All Rights Reserved.